With 15 INDs and 5 NDAs/BLAs to his name, Dr. Desai is a biotech veteran who’s led programs from discovery through approval. A proven entrepreneur and regulatory strategist, he brings high-stakes experience to our mission of developing CYT-108 as a first-in-class DMOAD.